Avalyn Pharma (AVLN) vs Oric Pharmaceuticals (ORIC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Oric Pharmaceuticals is the larger company by market cap ($1.24 billion vs $1.13 billion), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AVLN | ORIC |
|---|---|---|
| Share price | $25.53 | $12.01 |
| Market cap | $1.13B | $1.24B |
| 1-day change | +0.39% | +0.25% |
| YTD return | — | +46.82% |
| 1-year return | — | -14.94% |
| 5-year return | — | -26.00% |
| EPS (TTM) | $-2.47 | $-1.32 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $40.17 | $14.68 |
| 52-week low | $24.15 | $7.23 |
| Distance from 52-week high | -36.45% | -18.19% |
| Average volume | 238.20K | 1.47M |
| Shares outstanding | 44.33M | 103.65M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
AVLN vs ORIC FAQ
Which is bigger, Avalyn Pharma or Oric Pharmaceuticals?
Oric Pharmaceuticals (ORIC) is larger, with a market capitalization of $1.24B compared with $1.13B for Avalyn Pharma (AVLN).
Are Avalyn Pharma and Oric Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.